abstract |
Boron-containing nicotine analogs that have a selective partial agonist or antagonist property at the α7-containing nicotinic receptor subtypes are provided together with pharmaceutical compositions containing these compounds. Methods for the treatment of pathologies related to the central nervous system is also provided. |